How does presurgical chemotherapy influence the efficiency of treatment for esophageal cancer recurrence after curative esophagectomy?

Abstract

Background The effectiveness of treatments for recurrent esophageal squamous cell carcinoma (ESCC), particularly chemotherapy and chemoradiotherapy (CRT), remains unclear in patients who have previously been administered the same drugs during neoadjuvant chemotherapy. Methods In this retrospective study, 117 patients with recurrent thoracic ESCCs who had undergone curative resection were included. Patients were divided into two groups based on presurgical treatment: no presurgical treatment ( n = 74), and neoadjuvant chemotherapy ( n = 43). Prognosis after recurrence was analyzed differently in the group of patients who received CRT and chemotherapy for a recurrent site because of differences in recurrence patterns. Results There were no differences in patterns and times to recurrence between the patients who underwent each presurgical treatment. For treatment of recurrence, CRT was administered to 66 patients, chemotherapy to 32, surgical resection to 5, and best supportive care to 14. In patients who underwent CRT for local recurrence, the survival rates of those administered neoadjuvant chemotherapy were similar to those who did not receive any presurgical treatment ( P = 0.706). In patients who underwent chemotherapy for distant metastasis, the survival rates of those administered neoadjuvant chemotherapy were worse than in those who did not receive any presurgical treatment ( P = 0.028). Conclusions The effects of CRT for recurrent cancers are not influenced by neoadjuvant chemotherapy, even when using the same anticancer agent. Chemotherapy is an acceptable treatment for patients who do not receive presurgical treatment.

Potential Role of circPVT1 as a proliferative factor and treatment target in esophageal carcinoma

“…Esophageal cancer is one of the most aggressive squamous cell carcinomas, with more than 480,000 new cases diagnosed each year, making it the eighth most common cause of cancer death worldwide [1, 2]. It usually manifests as a high rate of lymph node metastasis, tumor invasion of adjacent tissues and organs, resulting in a large proportion of patients have metastasized before diagnosis [3, 4]. More than 80% of esophageal cancers are esophageal squamous cell carcinomas (ESCCs) [5].…”